Vulnerability in Medixant Radiant Dicom Viewer

CVE-2025-1001

Medixant RadiAnt DICOM Viewer is vulnerable due to failure of the update mechanism to verify the update server's certificate which could allow an attacker to alter network traffic and carry out a machine-in-the-middle attack (MITM). An attacker could modify the server's response and deliver a malicious update to the user.

Vulnerability class: Improper Certificate Validation

Published · last modified .

CVSS v3 metric

CVSS v3 base score 5.7 (Medium). Vector: CVSS:3.1/AV:A/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N.

EPSS exploit prediction

EPSS: 0.001 (2.9th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 3rd percentile — 2.9% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2025-1001: held from 0.001 to 0.001.

EPSS over last 30 days · oldest: 0.001 · newest: 0.001 · change: +0.000

Affected products

Weakness classification (CWE)

Public proof-of-concept exploits

References

Frequently asked questions

What is CVE-2025-1001?
CVE-2025-1001 is a medium-severity vulnerability in Medixant Radiant Dicom Viewer, classified under Improper Certificate Validation. CVSS score: 5.7/10. Published 2025-02-21.
How severe is CVE-2025-1001?
Medium severity. CVSS v3 base score is 5.7 out of 10.
Is CVE-2025-1001 known to be exploited?
1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.